Shandong Weigao Blood Purification Products Co. Ltd. (603014)
Market Open
11 Aug, 06:56
SSE SSE Primary ¥
33. 74
-0.12
-0.3544%
¥
14.75B Market Cap
- P/E Ratio
0.16% Div Yield
2.54M Volume
- Eps
¥ 33.86
Previous Close Want to track 603014 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shandong Weigao Blood Purification Products Co. Ltd. (603014) Statistics
Valuation metrics
Market Cap 14.75B
Enterprise value 12.22B
Trailing P/E (ttm) 29.63
Forward P/E 26.94
PEG ratio 26.94
Price/Sales (ttm) 3.94
Price/Book (mrq) 2.09
Enterprise Value/Revenue 3.24
Enterprise Value/EBITDA 15.61
Overview
Shares outstanding 417.75M
Float 65.16M
Shares short -
% Held by insiders 0.79%
% Held by institutions 0.04%
Average volume (10 days) 952.83K
Average volume (90 days) 885.84K
Price summary
52-Week low 29.7
52-Week high 49.01
Beta -
50-Day moving average 37.16
200-Day moving average 39.59
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.13%
Operating margin 0.15%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.08%
Income Statement
Revenue (ttm) 3.77B
Revenue per share (ttm) 9.53
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 1.51B
EBITDA 570.9M
Net income to common (ttm) 482.3M
Diluted EPS (ttm) 1.2
Quarterly earnings growth (yoy) 0.06%
Balance Sheet
Total cash (mrq) 2.81B
Total cash per share (mrq) 6.71
Total debt (mrq) 2.93M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 3.3%
Book value per share (mrq) 17.04
Cash Flow
Cash flow statement 793.71M
Levered free cash flow (LFCF) 500.49M
